Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards

National coalition led by the maker of the first and only FDA-cleared smart baby monitor on the market invites the community to join and amplify baby safety awareness efforts 

LEHI, Utah--(BUSINESS WIRE)--$owlt #babymonitor--Owlet, Inc. ("Owlet" or the "Company") (NYSE: OWLT), the pioneer of smart infant monitoring, is creating the Baby Safety Task Force, a committee convened to raise the standard for baby safety through education, product innovation, and advocacy. Kicking off during Baby Safety Month, Owlet is initiating this new task force and calls upon other brands, organizations, and thought leaders to join this effort.

“Our mission at Owlet is to help parents keep their baby safe and healthy at home,” said Kurt Workman, Owlet’s President, Chief Executive Officer, and Co-founder. “I believe brands that have direct access to parents can play a vital role in helping keep babies safe through innovation, education, and advocacy. Babies shouldn’t pass away unexpectedly at home yet sudden unexpected infant death (SUID) remains the leading cause of postneonatal infant mortality in the US, and rates haven’t changed in over 30 years.* There is a clear gap between understanding, implementing, and upholding infant safety standards, and that is why we're launching this task force. Closing that gap requires a coordinated effort across industry leaders, providers, and families.”

Owlet was founded with a clear vision: to help keep babies safe and give parents peace of mind. Everything Owlet does is an expression of that vision. More than 2.5 million parents have chosen Owlet to monitor their babies, and its Dream Sock^® earned De Novo FDA clearance in 2023, making it the first and only over-the-counter medical-grade pulse oximeter cleared for infants on the market. Dream Sock holds several global certifications, including a CE mark across the UK/EU and TGA approval in Australia and New Zealand. That vision also extends to data security: the Dream Sight^™ video monitor is the only baby monitor on the market to hold an SGS cybermark.

That mission doesn't stop at the products themselves. Through Owlet Cares, Owlet partners with 46 nonprofits that are dedicated to keeping babies safe and educating families about safe sleep, helping to bring Dream Sock to families who might not otherwise have access to this technology. Through this program, Owlet has given more than $2.5M in product and charitable donations to families in need and raised $160,000 for critical SIDS research. Owlet advocates in Washington, D.C., for the Baby Observation Act (BO's Act), H.R. 2168 / S. 3712, which would direct the Department of Health & Human Services (HHS) to study how in-home cardiorespiratory monitoring relates to rates of SUID. Whether through innovation, giving, or policy, Owlet is working toward one goal: safer nurseries and more confident parents.

The Baby Safety Task Force will unite thought leaders across the industry to spearhead education efforts, help families create safer environments, advocate for more rigorous baby safety standards, and encourage that baby products are held to the highest level of safety. Owlet invites brand leaders, healthcare providers, organizations, and advocates who want to do more when it comes to baby safety to join this effort. Visit www.owletcare.com/pages/baby-safety-task-force for more information and to apply.

* https://www.aafp.org/afp/2025/0200/sudden-infant-death-syndrome

About Owlet, Inc.

Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere.

Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children's well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life.

Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s plans and expectations for the Baby Safety Task Force; anticipated participation by brands, healthcare providers, organizations, advocates and other third parties; the Task Force’s planned education, advocacy and product-safety initiatives; the Company’s advocacy efforts relating to baby safety standards and the Baby Observation Act; and the Company’s goals and expectations regarding the potential impact of these and other initiatives on infant and baby safety. . In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “continues,” “designed,” “seek,” “will,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company’s future results and cause those results to differ materially from those expressed in or implied by the Company’s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet’s products, including its subscription services; (ii) the regulatory pathway for Owlet’s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA, the TGA and other similar regulators outside of the United States, as well as Owlet’s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iii) Owlet’s competition and the Company’s ability to profitably grow and manage growth; (iv) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (v) Owlet’s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy, data protection and cybersecurity, including for Owlet’s digital platforms and technologies; (vi) Owlet’s ability to maintain relationships with channel partners, customers, manufacturers and suppliers; (vii) impacts from compliance with applicable laws or regulations; (vii) the impact of and disruption to Owlet’s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company’s control; (ix) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (x) other risks and uncertainties set forth in the Company’s other releases, public statements and filings with the U.S. Securities and Exchange Commission (“SEC”), including those identified in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and as any such factors may be updated from time to time in the Company’s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company’s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.

Owlet Media Contacts:
pr@owletcare.com
owlet@hannahcranstonmedia.com

Owlet Investor Contact:
ir@owletcare.com